0
0
1/12/24 at 12:03pm
Organization
Drug Target Review
34 words
0
Comments
Genetic engineering created IgA antibodies that bind to the SARS-CoV-2 spike protein in a similar way to IgG antibodies.
You are the first to view
https://www.drugtargetreview.com/news/113613/nasal-administration-of-iga-antibodies-protects-from-sars-cov-2/
Create an account
or login to join the discussion